期刊文献+

重症病人甲状腺功能状态及其相关激素改变 被引量:10

Changes in Thyroid Function and Related Hormones in the Critically Ill Patients
下载PDF
导出
摘要 目的探讨重症病人合并非甲状腺疾病综合征(NTIS)时的特点,及其与皮质醇、生长激素(GH)、胰岛素样生长因子(IGF-1)等激素的相互关系。方法将38例重症病人按是否发生多器官功能不全综合征(MODS)分为MODS组(13例),非MODS组(25例)。入选后记录病人年龄、急性生理和慢性健康评分(APACHEⅡ),测定其血清T3、T4、促甲状腺激素(TSH)、皮质醇、GH、IGF-1等在疾病不同时期的动态变化和相互关系,以及相应的蛋白质代谢改变。结果甲状腺激素水平与疾病的严重程度密切相关。急性期两组病人血清甲状腺激素明显降低(P<0.01);T3与皮质醇和CRP改变呈负相关关系(P<0.05);TSH与GH呈正相关改变(P<0.01)。延迟期重症病人血清甲状腺激素与皮质醇仍表现为负相关关系(P=0.05),与其他激素之间无相关关系;与血清蛋白PAB、TRF正相关改变(P<0.01);非MODS组甲状腺激素水平恢复早于MODS组(P<0.05)。结论重症病人血清甲状腺激素水平与疾病严重程度密切相关,TSH、GH等垂体分泌释放激素水平下降提示NTIS时下丘脑-垂体轴功能受抑制;皮质醇改变亦与NTIS的发生相关;延迟期重症病人甲状腺激素与PAB、TRF等内脏蛋白改变与机体应激状态及高分解代谢有关。 Objective Pronounced alterations in the hypothalamus-pituitary-thyroid axis occur during critical illness without any pathologic changes of the thyroid gland. It is referred to as non-thyroidal illness syndrome(NTIS) or euthyroid sick syndrome(ESS). And it is still controversy about whether reduction in circulating thyroid hormone is an adaptation resulting in a protection against catabolism or whether it is a maladaptation contributing to a worsening of the disease. So the aim of this study is : 1 ) to explore the profile of changes in thyroid function in the critically ill. 2) to explore the relationship between these endocrintic factors and metabolic states in critical illness with non-thyroidal illness syndrome. Methods Patients admitted to the ICU from September 2004 until December 2005 were eligible for enrollment in this study. Inclusion criteria were intensive care dependency with APACHE Ⅱ score over ten and with an expected stay in the ICU for at least another 48 h. Exclusion criteria were: ① age less than 18 yrs; ② preexisting neurological conditions; ③hyperthyroidism hypothyroidism or other endocrine diseases; ④ intracranial lesions; ⑤ concomitant treatment with glucocorticoids and ⑥ pregnancy. A total of 38 patients with critical illness were investigated in this prospective clinical study, either with multiple organ dysfunction syndrome( MODS, n = 13) or without MODS(n = 25). Patients' age and APACHE Ⅱ scores were recorded at the first ICU- day and every 5th day. Serum T3, T4, thyrotropic-stimulating hormone(TSH) , cortisol, growth hormone(GH) and insulin-like growth factor-1 (IGF-1) were measured every 5-days; besides, the level of plasma albumin(ALB), prealbumin(PAB), transferrin (TRF) were measured at the same time. The data were analyzed by using T-test and bivariate correlations analysis. A P value 〈 0.05 was regarded as statistically significant in all the tests conducted in this study. Data were expressed as Mean ± S. Results Abnormality in circulating thyroid hormone was found in all patients in this study. The levels of serum thyroid hormone were declined markedly in patients with or without MODS(P 〈0.01 ). In MODS patients, recovery of declined of thyroid hormone wase slower than that in patients without MODS. A negati correlation was found between serum T3 and cortisol and C reactive protein( P 〈 0.05 ) in patients with acute critical illness, and a positive correlation was found between TSH and growth hormone( P 〈 0.01 ) at the same time. No significant correlation was found between thyroid hormone and other hormones except cortisol in prolonged phase. Meanwhile, changes in blood levels of prealbumin and thyroid hormone were closely related ( P 〈 0.01 ). Conclusion Adjustments in the thyroid axis in critical illness include a rapid decrease in T3, the bioactive thyroid hormone. And there are no compelling data to administer thyroid hormone in the so-called non-thyroidal illness syndrome. Since non-thyroidal illness syndrome occurs in most patients with systemic illness, and because the morbidity and mortality rate of NTI is high, it becomes important to determine whether thyroid hormone administration is beneficial or detrimental. This clinical studyreveals that : 1 ) the hypothalamus-pituitary-thyroid axis is affected during critical illness. Thyroid hormone and TSH are decreased in critically ill patients and correlated with the severity of critical illness. 2) down-regulated function of the hypothalamus-pituitary axis is observed with decrease in TSH and growth hormone. 3 ) decrease in serum thyroid hormone is negatively associated with elevation in cortisol level negatively during prolonged critical illness. 4) changes in prealbumin relate positively to the level of thyroid hormone in prolonged ICU patients.
出处 《首都医科大学学报》 CAS 2007年第5期587-591,共5页 Journal of Capital Medical University
关键词 危重病 甲状腺激素 皮质醇 生长激素 胰岛素样生长因子-1 代谢 critical illness thyroid hormone cortisol growth hormone IGF-1 metabolism
  • 相关文献

参考文献19

  • 1Slag M F,Morley J E,Elson M K,et al.Hypothyroxenemia in critically ill patients as predictor of high mortality[J].JAMA,1981,245:43-45.
  • 2Elvio S,Stefano B,Amir E,et al.Low triiodothyronine(T3) state:a predictor of outcome in respiratory failure? Results of a clinical pilot study[J].European J Endocrinology,2004,151:557-560.
  • 3Giorgio Iervasi,Alessandro Pingitore,Patrizia Landi,et al.Low-T3 syndrome a strong prognostic predictor of death in patients with heart disease[J].Circulation,2003,107:708-713.
  • 4Debapriya Datta,Paul Scalise.Hypothyroidism and failure to wean in patients receiving prolonged mechanical ventilation at a regional weaning center[J].CHEST,2004,126:1307-1312.
  • 5Hao Chih Ho,Alyssa D Chapital,Mihae Y.Hypothyroidism and adrenal insufficiency in sepsis and hemorrhagic shock[J].Arch Surg,2004,139:1199-1203.
  • 6Fliers E,Guldenaar S E F,Wiersinga W M,et al.Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with non-thyroidal illness[J].J Clin Endocrinol Metab,1997,82:4032-4036.
  • 7Van den Berghe G,de Zegher F,Veldhuis J D,et al.Thyrotropin and prolactin release in prolonged critical illness:dynamics of sponaneous secretion and effects of growth hormone secretagogues[J].Clin Endocrinol,1997,47:599-612.
  • 8Van den Berghe G,de Zegher F,Baxter R C,et al.Neuroendocrinology of prolonged critical illness:effect of continuous thyrotropin-releasing hormone infusion and its combination with growth hormone-secretagogues[J].J Clin Endocrinol Metab,1998,83:309-319.
  • 9Van den Berghe G,Wouters P,Weekers F,et al.Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness[J].J Clin Endocrinol Metab,1999,84:1311-1323.
  • 10Michalaki M,Vagenakis A G,Makri M,et al.Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery[J].J Clin Endocrinol Metab,2001,86:4198-4205.

同被引文献60

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部